Skip to main content
ABX logo

ABX · Abacus Global Management, Inc.

Track ABX — free
$6.53 -0.62 (-8.67%) At close · Nov 19
Market Cap
$638.58M
Shares
97.79M
Volume · Nov 19 1.09M Avg daily vol (3M) 694.4K

Price & Indicators

 

Key stats

Close
$6.53
Open
$7.04
Day range
$6.45–7.19
52-week closing range
$5.62–12.00
Average volume, 30 days
846K
Short interest
4.8M · 5.0% of shares · 8.2 days
Short volume, last session
63%
Last earnings
Nov 5, 2026
Latest filing
10-Q · Aug 10
Price history
Sep 2020 to Nov 2026

Up next

Mar 11, 2027 Est · unconfirmed · in 16 wks

Latest documents

2026
Nov 17
Late filing notice NT 10-Q
Quarterly report delayed; earlier periodic reports may need correction

Abacus Global Management will miss its deadline for the quarter ended September 30, 2026, pending review of limited partner capital credits and related-party transactions. Earlier reports back to June 30, 2025 may need correction.

3 source passages
Abacus Global Management, Inc. (the “Company” or “Registrant”) is unable to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 (the “Form 10-Q”) within the prescribed time period without unreasonable effort or expense. The Company’s delay in timely filing its Form 10-Q is a result of its ongoing evaluation of the accounting for capital account credits provided to the limited partners of certain private funds advised by the Company starting in the second quarter of 2025, as well as the accounting associated with certain transactions between the Company and its related party funds. After the evaluation of the above items is completed, the Company will evaluate the materiality of any identified issues in the Company’s previously filed periodic reports, potentially dating back to June 30, 2025, to determine whether corrections are required. Open the document at this passage
Nov 5
Earnings call
Raises guidance after earnings beat

Third-quarter adjusted net income reached $29.4 million, above $26 to $28 million guidance, as Abacus Global Management raised full-year 2026 adjusted net income guidance to $104.5 to $106.5 million from $100 to $106 million.

3 source passages
Abacus Global Management's third quarter earnings call. Third quarter adjusted net income of $29.4 million came in above the top end of the $26 to $28 million range we guided to last quarter. Based on that strong performance, we are raising our full year 2026 guidance for the second time this year. We now expect adjusted net income of $104.5 to $106.5 million, up from $100 to $106 million, and adjusted EPS of $1.05 to $1.07, up from $1.05 to $1.05. Open the document at this passage
Nov 5
Current report 8-K
Record revenue, raised guidance, and higher dividend

Abacus Global Management reported third-quarter revenue of $76.9 M, adjusted net income of $29.4 M and adjusted EPS of $0.29, raised full-year 2026 adjusted net income guidance to $104.5M to $106.5M, and approved a $0.22 dividend payable December 16, 2026.

Financial results, Other events
4 source passages
~ Reports Record Third Quarter 2026 Total Revenue of $76.9 Million ~ ~ Third Quarter Adjusted Net Income1 of $29.4 Million and Adjusted EPS1 of $0.29 Exceed High End of Guidance Ranges; Adjusted EBITDA1 Grows to Record $42.3 Million ~ ~ Raises Full-Year 2026 Adjusted Net Income¹ Guidance to $104.5–$106.5 Million, Up to 24% Year-Over-Year; Projects Fourth Quarter Adjusted EPS¹ of $0.28–$0.30, Up to 30% Year-Over-Year ~ On November 5, 2026, the Board of the Company approved an annual cash dividend of $0.22 per share to be paid on December 16, 2026 to shareholders of record of the Company as of the close of business on December 1, 2026. Open the document at this passage
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$267.28M
Trailing 12 months
Net income (TTM)
$27.44M
Trailing 12 months
Revenue growth YoY
+29.9%
Year over year
Operating margin
31.8%
Trailing 12 months
P / E (TTM)
24.2
Trailing earnings · reciprocal yield 4.1%
FCF yield
14.0%
TTM · current market cap
Return on invested capital
7.0%
Trailing 12 months
Net cash
−$307.22M
Latest balance sheet
Dividend yield
3.1%
Trailing 12 months
Shares change YoY
+1.1%
Year over year · more shares
Price change (1Y)
+9.2%
Trailing year
Short interest
5.0%
Latest settlement · 8.2 days to cover
View all 125 metrics

AI Brief

Q2 FY26 earnings call · Aug 6, 2026
Q2 FY26

TL;DR. Abacus reported record Q2 revenue of $73.0M (+30% YoY) and adjusted EPS of $0.28, beating its guidance, and raised its Q3 adjusted EPS outlook to $0.26–$0.28 while reiterating full-year guidance of $1.00–$1.05. Longevity fund inflows of $544.2M in 1H26 surpassed the $500M target, the company launched its first registered interval fund (ABXGX), and GAAP net income declined 63% YoY due to acquisition-related and growth expenses.

Bullish
  • + Record Q2 revenue of $73.0M, up 30% YoY, driven by Life Solutions growth of 38.3%.
  • + Longevity funds raised $544.2M in 1H26, surpassing the $500M target and approaching the ~$604M raised in all of 2025.
  • + Launched the ABX Longevity Growth and Income Fund (ABXGX), the first registered interval fund for the longevity asset class, opening access to individual investors.
  • + Q3 guidance implies adjusted EPS up to 17% YoY at $0.26–$0.28, and management is targeting the top end of the reiterated full-year range.
Bearish
  • − Asset management revenue declined YoY, driven by ETF AUM declines from market conditions and outflows.
  • − Full-year adjusted EPS guidance of $1.00–$1.05 was reiterated rather than raised, even after a Q2 beat and higher Q3 outlook.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 28.4 · fear Equity put/call 0.72
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −29%
below
Price vs 50-day avg −22%
below
RSI (14) 30
oversold
MACD trend Negative
52-week position 14%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −23%
trailing
6-month return −28%
trailing
YTD return −24%
this year
Relative strength −22%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $8 › 200d $9 — 200d above 50d
Institutional flow Accumulating
+1% holders QoQ · +24 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
4.95% of shares out · ▲ +1.9% MoM · 8.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
150 holders — near 3-yr high, broad support
Squeeze score 66
elevated · 0–100
Fundamentals
Fair
Revenue growth +110%
Y/Y
Gross margin 88%
contracting
EPS growth +206%
Y/Y
Free cash flow $-26.6M
Valuation P/E 24.2
rich
Buyback $100.0M
authorized
Balance sheet $367.7M
net debt
Quant / Vol
risk profile
Very High
Volatility 57%
annualized · 1-yr
Max drawdown −46%
past year
ATR 10.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Nov 5, 2026
full year 2026
Adjusted net income Non-GAAP Raised $104.5M – $106.5M
Aug 6, 2026 $100M – $106M changed to Nov 5, 2026 $104.5M – $106.5M
Adjusted EPS Non-GAAP Raised $1.05 – $1.07
Aug 6, 2026 $1.00 – $1.05 changed to Nov 5, 2026 $1.05 – $1.07
fourth quarter
Adjusted net income Non-GAAP Initiated $28M – $30M
Adjusted EPS Non-GAAP Initiated $0.28 – $0.30
Previous outlook earlier release · from the Earnings Call filed Mar 12, 2026

Still-open targets the latest release did not restate under the same label.

Fee-paying AUM · year-end 2026 $5B
Prior guidance period ended · from the Earnings Call filed Aug 6, 2026
Adjusted net income · the third quarter $26M – $28M
Adjusted EPS · the third quarter $0.26 – $0.28

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−29% Bearish
Price vs 50-day avg
−22% Bearish
RSI (14)
30 Neutral
MACD trend
Negative Bearish
52-week position
14% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $8 › 200d $9 — 200d above 50d
Institutional flow Accumulating
+1% holders QoQ · +24 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
4.95% of shares out · ▲ +1.9% MoM · 8.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
150 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $6 Now $7 · 14% Range high $12
vs 200-day avg -29% vs 50-day avg -22%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Average management fee on ETF Funds 0.45% Three Months Ended June 30, 2026 filing —
Average management fee on Longevity Funds 1.05% Three Months Ended June 30, 2026 filing —
Holding period on existing policies (in days) 153 Three Months Ended June 30, 2026 filing —
Holding period on sold policies (in days) 230 Three Months Ended June 30, 2026 filing —
Number of external counter parties that purchased policies 6 Three Months Ended June 30, 2026 filing —
Number of policy originations to subsidiaries eliminated in consolidation 138 Three Months Ended June 30, 2026 filing —
Policies bought 288 Three Months Ended June 30, 2026 filing —
Policies bought from related parties 8 Three Months Ended June 30, 2026 filing —
Policies matured 19 Three Months Ended June 30, 2026 filing —
Policies originated for external investors 44 Three Months Ended June 30, 2026 filing —
Policies sold 300 Three Months Ended June 30, 2026 filing —
Policies sold to related parties 278 Three Months Ended June 30, 2026 filing —
Total lifetime realized gains from maturities, net of lifetime premiums paid $19,268,981 Three Months Ended June 30, 2026 filing —
Total lifetime realized gains, net of lifetime premiums paid $62,032,077 Three Months Ended June 30, 2026 filing —
Turnover ratio 2% Three Months Ended June 30, 2026 filing —
Weighted average realized gain on policies sold 25.2% Three Months Ended June 30, 2026 filing —
Adjusted Annualized ROE non-GAAP 22% Six Months Ended June 30, 2026 —
Adjusted Annualized ROIC non-GAAP 20% Six Months Ended June 30, 2026 —
Adjusted EBITDA non-GAAP $72,596,972 Six Months Ended June 30, 2026 —
Adjusted EBITDA Margin non-GAAP 54.8% Six Months Ended June 30, 2026 —
Adjusted EPS (Gross) non-GAAP $0.28 2Q26 —
Adjusted EPS - Basic non-GAAP $0.41 Six Months Ended June 30, 2026 —
Adjusted EPS - Diluted non-GAAP $0.4 Six Months Ended June 30, 2026 —
Adjusted Net Income non-GAAP $39,497,137 Six Months Ended June 30, 2026 —
Adjusted net income (Gross) non-GAAP 27.1M 2Q26 —
Annualized ROE non-GAAP 25% 2Q26 —
Annualized ROIC non-GAAP 23% 2Q26 —
Average realized gain 25% 2Q26 —
Longevity funds capital inflows 256.1M 2Q26 —
Longevity funds new capital raised 544.2M first half of 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Insurance - Life — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ABX
Abacus Global Management, Inc.
this stock
$638.58M -23.6% +110.2% 24.2 5.0%
CILJF
China Life Insurance Co Ltd
$77.85B -20.2% — — 0.0%
MFC
Manulife Financial Corp
$69.73B +16.3% — — 0.8%
AFL
Aflac Inc
$61.71B +13.1% -9.3% 18.4 1.8%
MET
Metlife Inc
$61.34B +23.6% +8.6% 12.7 1.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
150
% held
29.8%
Net QoQ
+1.8M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
123
View
Short & Settlement
Short Interest Rising
Shares short
4.8M
Days to cover
8.2d
Change
+90.1K sh
View
Short Volume
Short vol %
63%
As of
Nov 19, 2026
Short Total
View
Fails to Deliver
FTD shares
163
Value
$1.3K
As of
Oct 19, 2026
View
Off-Exchange
Off-exchange %
32.9%
Week of
Oct 12, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$235.2M
Net income (FY)
$36.5M
EPS diluted
$0.36
View
Buybacks
Authorized
$100.0M
View
Filings
SEC Filings
Latest
NT 10-Q
Filed
Nov 17, 2026
This year
23

Abacus Global Management will miss its deadline for the quarter ended September 30, 2026, pending review of limited partner capital credits and related-party transactions. Earlier reports back to June 30, 2025 may need correction.

View
Proposed Sales
Value
$1.2M
Shares
125.0K
Filed
Aug 19, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 5, 2026
View
Investor Relations
Latest news
Abacus Global Management Announce…
Published
Nov 11, 2026
View

Performance

5D 20D 120D MTD YTD
ABX -25.6% -23.3% -27.9% -22.9% -23.6%
SPY -5.5% -6.3% -5.6% -5.3% +5.0%
vs SPY -20.2% -17.0% -22.2% -17.6% -28.6%

Capital returns

Latest dividend
$0.20 / share · ex Dec 2, 2025
Declared · upcoming
$0.22 / share · ex Dec 1, 2026
Paid (TTM)
$0.20 / share · 1 payout
Dividend yield (TTM, derived)
— · history filling in
Full dividend history
Buyback program · as of Nov 5, 2026
Authorized
$100.00M
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1814287 CUSIP 00258Y104 13F (30d) 149 filings 141 filers Visit website Investor relations